Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mainz Biomed (MYNZ) Shares Outstanding (Weighted Average) (2020 - 2025)

Mainz Biomed's Shares Outstanding (Weighted Average) history spans 5 years, with the latest figure at $968234.0 for Q4 2024.

  • For Q4 2024, Shares Outstanding (Weighted Average) rose 138.45% year-over-year to $968234.0; the TTM value through Dec 2024 reached $968234.0, up 138.45%, while the annual FY2024 figure was $968234.0, 138.45% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2024 was $968234.0 at Mainz Biomed, up from $406058.0 in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $7.2 million in Q4 2021 and bottomed at $353937.0 in Q4 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $968234.0 (2024), against an average of $2.9 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) crashed 95.09% in 2022 before it skyrocketed 138.45% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $5.6 million in 2020, then grew by 28.6% to $7.2 million in 2021, then plummeted by 95.09% to $353937.0 in 2022, then rose by 14.73% to $406058.0 in 2023, then surged by 138.45% to $968234.0 in 2024.
  • Per Business Quant, the three most recent readings for MYNZ's Shares Outstanding (Weighted Average) are $968234.0 (Q4 2024), $406058.0 (Q4 2023), and $353937.0 (Q4 2022).